Last update 21 Mar 2025

Tetravalent influenza vaccine (Chengda Bio)

Overview

Basic Info

Drug Type
Live attenuated vaccine, Prophylactic vaccine, Multivalent vaccine
Synonyms
Influenza Vaccine (Split Virion),Inactivated,Quadrivalent (Chengda Bio)
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
Influenza, Human
Inactive Indication-
Originator Organization
Liaoning Chengda Biotechnology Co. Ltd.Liaoning Chengda Biotechnology Co. Ltd.
Active Organization
Chengda Biotechnology Benxi Co. Ltd.
Inactive Organization-
Drug Highest PhaseNDA/BLA
First Approval Date-
Regulation-
Login to view timeline

Related

5
Clinical Trials associated with Tetravalent influenza vaccine (Chengda Bio)
CTR20240998
/ CompletedPhase 3
评价四价流感病毒裂解疫苗接种于3周岁及以上健康人群的免疫原性和安全性的随机、双盲、阳性对照的III期临床试验
[Translation] A randomized, double-blind, positive-controlled phase III clinical trial to evaluate the immunogenicity and safety of quadrivalent influenza virus split vaccine in healthy people aged 3 years and above
CTR20202605
/ Active, not recruitingPhase 3
评价四价流感病毒裂解疫苗接种于3周岁及以上人群的免疫原性和安全性的随机、盲法、阳性对照的 Ⅲ 期临床试验
[Translation] A randomized, blinded, positive-controlled phase III clinical trial to evaluate the immunogenicity and safety of quadrivalent influenza virus split vaccine in people aged 3 years and above
CTR20202473
/ CompletedPhase 1
评价四价流感病毒裂解疫苗接种于3周岁及以上人群的安全性的Ⅰb期临床试验
[Translation] Phase Ib clinical trial to evaluate the safety of quadrivalent influenza virus split vaccine in people aged 3 years and above
100 Clinical Results associated with Tetravalent influenza vaccine (Chengda Bio)
Login to view more data
100 Translational Medicine associated with Tetravalent influenza vaccine (Chengda Bio)
Login to view more data
100 Patents (Medical) associated with Tetravalent influenza vaccine (Chengda Bio)
Login to view more data
100 Deals associated with Tetravalent influenza vaccine (Chengda Bio)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Influenza, HumanNDA/BLA
China
Chengda Biotechnology Benxi Co. Ltd.
24 Jan 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free